Caribou Biosciences Reports First Quarter 2024 Financial Results and Provides Business Update
May 07, 2024 16:05 ET
|
Caribou Biosciences, Inc.
-- Advancing CB-010 ANTLER Phase 1 trial in 2L LBCL; initial dose expansion data to be presented at the 2024 American Society of Clinical Oncology (ASCO) Annual Meeting -- -- Expanding into...
ClearPoint Neuro Reports First Quarter 2024 Results
May 07, 2024 16:05 ET
|
ClearPoint Neuro, Inc.
Q1-2024 Revenue Growth +41%, a Company Record
Veeco Reports First Quarter 2024 Financial Results
May 07, 2024 16:05 ET
|
Veeco Instruments Inc.
First Quarter 2024 Highlights: Revenue of $174.5 million, compared with $153.5 million in the same period last yearGAAP net income of $21.9 million, or $0.37 per diluted share, compared with $8.7...
Latham Group, Inc. Reports First Quarter 2024 Financial Results
May 07, 2024 16:05 ET
|
Latham Pool Products
First Quarter Results Benefitted from Strong Execution, Cost Savings, and Value Engineering and Productivity InitiativesFiberglass Pools Continued to Show Relative StrengthCompany Re-Affirms Full Year...
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2024 Financial Results
May 07, 2024 16:05 ET
|
Aligos Therapeutics
SOUTH SAN FRANCISCO, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Aligos Therapeutics, Inc. (Nasdaq: ALGS, “Aligos”), a clinical stage biopharmaceutical company focused on developing novel therapeutics...
Open Lending Reports First Quarter 2024 Financial Results
May 07, 2024 16:05 ET
|
Open Lending Corporation
AUSTIN, Texas, May 07, 2024 (GLOBE NEWSWIRE) -- Open Lending Corporation (Nasdaq: LPRO) (the “Company” or “Open Lending”), an industry trailblazer in lending enablement and risk analytics solutions...
Sight Sciences to Present at the Upcoming Bank of America Healthcare Conference
May 07, 2024 16:05 ET
|
Sight Sciences, Inc.
MENLO PARK, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (“Sight Sciences” or the “Company”), an eyecare technology company focused on developing and commercializing...
Immuneering Reports First Quarter 2024 Financial Results and Provides Business Updates
May 07, 2024 16:05 ET
|
Immuneering Corporation
Immuneering Reports First Quarter 2024 Financial Results and Provides Business Updates
Nature’s Sunshine Reports Strong First Quarter 2024 Results
May 07, 2024 16:05 ET
|
Nature's Sunshine Products, Inc.
LEHI, Utah, May 07, 2024 (GLOBE NEWSWIRE) -- Nature’s Sunshine Products, Inc. (Nasdaq: NATR) (Nature’s Sunshine), a leading natural health and wellness company offering high-quality herbal and...
Oculis Publishes Invitation to the Annual General Meeting
May 07, 2024 16:05 ET
|
Oculis Holding AG
Zug, Switzerland, May 07, 2024 (GLOBE NEWSWIRE) -- Oculis Holding AG (Nasdaq Global Market: OCS) (“Oculis”), has published the invitation to the 2024 Annual General Meeting, which will be held on...